Antidepressant and antipsychotic treatment in patients with cardiac diseases: Drug choice and issues to be considered Kalp hastalarinda antidepresan ve antipsikotik tedavide ilaç seçimi ve dikkat edilmesi gereken özellikler
Turk Kardiyoloji Dernegi Arsivi, cilt.33, sa.4, ss.233-240, 2005 (Scopus, TRDizin)
- Yayın Türü: Makale / Derleme
- Cilt numarası: 33 Sayı: 4
- Basım Tarihi: 2005
- Dergi Adı: Turk Kardiyoloji Dernegi Arsivi
- Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.233-240
- Anahtar Kelimeler: Antidepressive agents, tricyclic, Antipsychotic agents, Anxiety disorders, Cardiovascular diseases, Comorbidity, Coronary disease, Depressive disorder, Serotonin uptake inhibitors
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
The use of antidepressant and antipsychotic drugs is not generally well-appreciated among physicians other than psychiatrists. Like almost all drugs, they are not devoid of cardiovascular effects. Since cardiac disorders and psychiatric diseases may well coexist, implications of this coexistence should be considered. In this article, the use of antidepressant and antipsychotic therapy is reviewed in patients with cardiac diseases in terms of role, safety, adverse effects, and treatment choice.